These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30461064)

  • 21. Evaluation of two inflammation-based prognostic scores in patients with resectable gallbladder carcinoma.
    Wu XS; Shi LB; Li ML; Ding Q; Weng H; Wu WG; Cao Y; Bao RF; Shu YJ; Ding QC; Mu JS; Gu J; Dong P; Liu YB
    Ann Surg Oncol; 2014 Feb; 21(2):449-57. PubMed ID: 24081806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Raised CA19-9 and CEA have prognostic relevance in gallbladder carcinoma.
    Sachan A; Saluja SS; Nekarakanti PK; Nimisha ; Mahajan B; Nag HH; Mishra PK
    BMC Cancer; 2020 Aug; 20(1):826. PubMed ID: 32867709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single and combined use of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and carcinoembryonic antigen in diagnosing gastric cancer.
    Wu Y; Jiang M; Qin Y; Lin F; Lai M
    Clin Chim Acta; 2018 Jun; 481():20-24. PubMed ID: 29476736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma.
    Dalpiaz O; Luef T; Seles M; Stotz M; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC; Pichler M
    Br J Cancer; 2017 Jan; 116(1):85-90. PubMed ID: 27907929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma.
    Lee GW; Park SW; Go SI; Kim HG; Kim MK; Min CK; Kwak JY; Bae SB; Yoon SS; Lee JJ; Kim KH; Nam SH; Mun YC; Kim HJ; Bae SH; Shin HJ; Lee JH; Park JS; Jeong SH; Lee MH; Lee HS; Park KW; Lee WS; Lee SM; Lee JO; Hyun MS; Jo DY; Lim SN; Lee JH; Kim H; Cho DY; Do YR; Kim JA; Park SK; Kim JS; Kim SJ; Yi HG; Moon JH; Choi CW; Kim SH; Kim BS; Park MR; Shim H; Song MK; Kim Y; Kim K
    Acta Haematol; 2018; 140(3):146-156. PubMed ID: 30253397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic impact of immune inflammation biomarkers in predicting survival and radiosensitivity in patients with non-small-cell lung cancer treated with chemoradiotherapy.
    Delikgoz Soykut E; Kemal Y; Karacin C; Karaoglanoglu O; Kurt M; Aytac Arslan S
    J Med Imaging Radiat Oncol; 2022 Feb; 66(1):146-157. PubMed ID: 34632714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baseline derived neutrophil-to-lymphocyte ratio as a prognostic biomarker for non-colorectal gastrointestinal cancer patients treated with immune checkpoint blockade.
    Li S; Zou J; Liu C; Jiao X; Gong J; Li J; Wang Z; Lu M; Lu Z; Shen L
    Clin Immunol; 2020 Mar; 212():108345. PubMed ID: 31953149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab.
    Capone M; Giannarelli D; Mallardo D; Madonna G; Festino L; Grimaldi AM; Vanella V; Simeone E; Paone M; Palmieri G; Cavalcanti E; Caracò C; Ascierto PA
    J Immunother Cancer; 2018 Jul; 6(1):74. PubMed ID: 30012216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum albumin and derived neutrophil-to-lymphocyte ratio are potential predictive biomarkers for immune checkpoint inhibitors in small cell lung cancer.
    Kuang Z; Miao J; Zhang X
    Front Immunol; 2024; 15():1327449. PubMed ID: 38911864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.
    Dalpiaz O; Pichler M; Mannweiler S; Martín Hernández JM; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC
    Br J Cancer; 2014 May; 110(10):2531-6. PubMed ID: 24691424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High score of LDH plus dNLR predicts poor survival in patients with HER2-positive advanced breast cancer treated with trastuzumab emtansine.
    Li L; Ai L; Jia L; Zhang L; Lei B; Zhang Q
    BMC Cancer; 2022 Jan; 22(1):29. PubMed ID: 34980025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association between albumin-dNLR score and disease activity in patients with rheumatoid arthritis.
    Chen S; Ying H; Du J; Zhu X; Shi J; Zhang Y; Chen S; Shen B; Li J
    J Clin Lab Anal; 2019 Mar; 33(3):e22695. PubMed ID: 30320486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative circulating FPR and CCF score are promising biomarkers for predicting clinical outcome of stage II-III colorectal cancer patients.
    Sun F; Peng HX; Gao QF; Li SQ; Zhang J; Chen QG; Jiang YH; Zhang L; Wang XZ; Ying HQ
    Cancer Manag Res; 2018; 10():2151-2161. PubMed ID: 30050325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of Prognostic Markers {CEA, Ca19.9, Neutrophil To Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR)} With Progression Free Survival (PFS) in Advanced/Metastatic Gallbladder Carcinoma.
    Naik MD; Kataria SP; Kumar G; Singh R
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of preoperative NLR, PLR and CEA could increase the diagnostic efficacy for I-III stage CRC.
    Peng HX; Yang L; He BS; Pan YQ; Ying HQ; Sun HL; Lin K; Hu XX; Xu T; Wang SK
    J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27686880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor Marker Kinetics as Prognosticators in Patients with Unresectable Gallbladder Adenocarcinoma Undergoing Palliative Chemotherapy.
    Lee JW; Kim YT; Lee SH; Son JH; Kang JW; Ryu JK; Jang DK; Paik WH; Lee BS
    Gut Liver; 2018 Jan; 12(1):102-110. PubMed ID: 29069888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between preoperative inflammatory markers, Ki-67 and the pathological grade of glioma.
    Xu G; Li C; Wang Y; Ma J; Zhang J
    Medicine (Baltimore); 2021 Sep; 100(36):e26750. PubMed ID: 34516487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete Blood Count Score Model Integrating Reduced Lymphocyte-Monocyte Ratio, Elevated Neutrophil-Lymphocyte Ratio, and Elevated Platelet-Lymphocyte Ratio Predicts Inferior Clinical Outcomes in Adult T-Lymphoblastic Lymphoma.
    Feng X; Li L; Wu J; Zhang L; Sun Z; Li X; Wang X; Yu H; Chang Y; Wu X; Zhou Z; Wang G; Li W; Li Z; Zhang X; Zhang M
    Oncologist; 2019 Nov; 24(11):e1123-e1131. PubMed ID: 30952822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphocyte-to-monocyte ratio effectively predicts survival outcome of patients with obstructive colorectal cancer.
    Chen XQ; Xue CR; Hou P; Lin BQ; Zhang JR
    World J Gastroenterol; 2019 Sep; 25(33):4970-4984. PubMed ID: 31543687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.